Project42sp. z o.o.

Other professional, scientific and technical activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-29
Share capital
5,000.00 PLN
Activity description

P42med develops computational drug-design tools focused on GPCR allosteric modulation. The company combines molecular dynamics simulations, graph neural networks, and information-theoretic analysis to design molecules and allosteric modulator peptides. It also provides a cloud-based pipeline for MD simulations, ML scoring, and automated molecule optimisation.

Registered address
ul. Bagatela 15/73, 00-585 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 2 of 5 financial statements were filed late (the longest delay 94 days for 2021).

  • 2024not filed
  • 202329/07/2024
  • 202229/06/2023
  • 202117/10/2022
  • 202014/07/2021
  • 201914/10/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Voivodeship · Mazowieckie140,465 / 142,048
Top 99%
Country · Poland491,585 / 495,935
Top 99%

Results vs industry

Revenue
This companyUSD 0.09MedianUSD 70.15kAverageUSD 515.83k
Net profit
This companyUSD -4.76kMedianUSD 2.51kAverageUSD 5.45k
Operating costs
This companyUSD 4.51kMedianUSD 57.09kAverageUSD 446.62k
Assets
This companyUSD 7.81kMedianUSD 61.04kAverageUSD 1.39m

Authorized Representatives

Kamil Adam Mieszkowskiage 36 – Management Board Member
Maciej Paweł Ciemnyage 35 – Management Board Member

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company shall be made by the member of the management board. In the case of a management board composed of two or more persons, joint action by two members of the management board or by one member of the management board with a commercial proxy shall be required to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
50$675.3150%
50$675.3150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-06-15.

  • mBank
    36 1140 2004 0000 3102 8116 7261
  • mBank
    45 1140 2004 0000 3002 8426 0090

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $36,163.

PurposeGross amount
Aid for research and development projects: industrial research
$0
Aid for research and development projects: experimental development
$0
Aid for SME access to finance — aid for start-ups
$30,433

Change history

DateEvent
2024-09-02Address change
2019-09-04Address change
2019-03-29Entered in the register

FAQ

Last updated: 2026-04-12